摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(4-fluorobenzylidene)-2-piperidone | 607731-27-1

中文名称
——
中文别名
——
英文名称
3-(4-fluorobenzylidene)-2-piperidone
英文别名
3-(4-fluorobenzylidene)piperidin-2-one;3-(p-fluorobenzylidene)-2-piperidone;3-[(4-Fluorophenyl)methylidene]piperidin-2-one
3-(4-fluorobenzylidene)-2-piperidone化学式
CAS
607731-27-1
化学式
C12H12FNO
mdl
——
分子量
205.232
InChiKey
BLKNAAHKUZGRNB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    170 °C
  • 沸点:
    405.6±45.0 °C(Predicted)
  • 密度:
    1.200±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    15
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    29.1
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    3-(4-fluorobenzylidene)-2-piperidone 在 lithium aluminium tetrahydride 、 palladium 10% on activated carbon 、 氢气 作用下, 以 四氢呋喃甲醇 为溶剂, 15.0~30.0 ℃ 、480.55 kPa 条件下, 反应 8.0h, 生成 3-(4-氟苄基)-哌啶
    参考文献:
    名称:
    Stereoselective Process for a CCR3 Antagonist
    摘要:
    A convergent, multikilogram, stereoselective synthesis of 1 is described. A key fragment, (S)-3-(4-fluorobenzyl)piperidine (2) was synthesized from valerolactam in three steps using our recently discovered Ir-BDPP-catalyzed asymmetric hydrogenation. Another key fragment, (IR,2R)-2-(benzyloxycarbonylamino)cyclohexanecarboxaldehyde (3) was synthesized from meso-hexahydrophthalic anhydride in seven steps. The stereochemistry was set in the first step of this sequence via a quinidine-mediated desymmetrization of the meso-anhydride. Coupling of the fragments 2 and 3 followed by deprotection provided the penultimate 23. The active pharmaceutical ingredient (API) free base I was obtained by treatment of 23 with the aminothiazole fragment 4 under mild conditions.
    DOI:
    10.1021/op050202l
  • 作为产物:
    描述:
    哌啶酮potassium tert-butylate 作用下, 以 四氢呋喃甲苯叔丁醇 为溶剂, 反应 2.5h, 生成 3-(4-fluorobenzylidene)-2-piperidone
    参考文献:
    名称:
    Stereoselective Process for a CCR3 Antagonist
    摘要:
    A convergent, multikilogram, stereoselective synthesis of 1 is described. A key fragment, (S)-3-(4-fluorobenzyl)piperidine (2) was synthesized from valerolactam in three steps using our recently discovered Ir-BDPP-catalyzed asymmetric hydrogenation. Another key fragment, (IR,2R)-2-(benzyloxycarbonylamino)cyclohexanecarboxaldehyde (3) was synthesized from meso-hexahydrophthalic anhydride in seven steps. The stereochemistry was set in the first step of this sequence via a quinidine-mediated desymmetrization of the meso-anhydride. Coupling of the fragments 2 and 3 followed by deprotection provided the penultimate 23. The active pharmaceutical ingredient (API) free base I was obtained by treatment of 23 with the aminothiazole fragment 4 under mild conditions.
    DOI:
    10.1021/op050202l
点击查看最新优质反应信息

文献信息

  • Chemical‐Reductant‐Free Electrochemical Deuteration Reaction using Deuterium Oxide
    作者:Xu Liu、Ruoyu Liu、Jiaxing Qiu、Xu Cheng、Guigen Li
    DOI:10.1002/anie.202005765
    日期:2020.8.10
    We report a method for the electrochemical deuteration of α,β‐unsaturated carbonyl compounds under catalyst‐ and external‐reductant‐free conditions, with deuteration rates as high as 99 % and yields up to 91 % in 2 h. The use of graphite felt for both the cathode and the anode was key to ensuring chemoselectivity and high deuterium incorporation under neutral conditions without the need for an external
    我们报告了一种在无催化剂和无外部还原剂的条件下对α,β-不饱和羰基化合物进行电化学化的方法,化率高达99%,在2小时内产率高达91%。阴极和阳极同时使用石墨毡是确保在中性条件下无需外部还原剂的情况下化学选择性和高掺入的关键。与先前报道的使用化学计量的属还原剂的代反应相比,该方法具有许多优点。机理实验表明,阳极处的O 2析出不仅消除了对外部还原剂的需求,而且还调节了反应混合物的pH值,使其保持中性。
  • Gold(I)-Catalysed Hydroarylation of Lactam-Derived Enynes as an Entry to Tetrahydrobenzo[<i>g</i> ]quinolines
    作者:Stefano Nejrotti、Simone Ghinato、Elena C. Gini、Dina Scarpi、Ernesto G. Occhiato、Andrea Maranzana、Cristina Prandi
    DOI:10.1002/ejoc.201901599
    日期:2020.2.14
    The gold(I)‐catalysed cyclization of N‐tosyl‐protected 5‐benzyl‐6‐((trimethylsilyl)ethynyl)‐1,2,3,4‐tetrahydropyridines, prepared by Sonogashira coupling of lactam‐derived enol triflates, provides tetrahydrobenzo[g]quinolones. The Au(I)‐catalysed reaction is carried out with (C6F5)3PAuCl/AgNTf2 and proceeds via a 6‐exo‐dig cyclization to the aromatic tetrahydrobenzo[g]quinolines. The mode of cyclization
    由内酰胺衍生的三氟甲磺酸钠的Sonogashira偶合制备的(I)催化的N-甲苯磺酰基保护的5-苄基-6-(((三甲基硅烷基)乙炔基)1,2,3,4-四氢吡啶的环化反应提供四并[ g ]喹诺酮类。在Au(I) -催化的反应是用(C进行6 ˚F 5)3 PAuCl / AgNTf 2经由6-并且进行外切-挖环化为芳族四并[克]喹啉。DFT计算讨论并支持了环化模式。
  • Process for the manufacture of optically active 3-substituted lactams by asymmetric hydrogenation of 3-alkylidenelactams
    申请人:——
    公开号:US20040010139A1
    公开(公告)日:2004-01-15
    The present invention relates generally to processes for the efficient production optically active 3-substituted lactams of formula (I) 1 process, comprising: contacting a compound of formula (II): 2 with hydrogen under a suitable pressure in the presence of an iridium complex of the formula (R 2 )IrL + X − wherein L is a chelating diene, X is a non coordinating anion, and R 2 is selected from 3
    本发明通常涉及一种高效生产光学活性的3-取代内酰胺的方法,其中包括:将式(II)的化合物与在适当压力下在(R2)IrL+X−的配合物存在下接触,其中L是螯合二,X是非配位阴离子,R2是选择自3。
查看更多

同类化合物

(R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 ((3S,4R)-3-氨基-4-羟基哌啶-1-基)(2-(1-(环丙基甲基)-1H-吲哚-2-基)-7-甲氧基-1-甲基-1H-苯并[d]咪唑-5-基)甲酮盐酸盐 高氯酸哌啶 高托品酮肟 马来酸帕罗西汀 颜料红48:4 顺式3-氟哌啶-4-醇盐酸盐 顺式2,6-二甲基哌啶-4-酮 顺式1-苄基-4-甲基-3-甲氨基-哌啶 顺式-叔丁基4-羟基-3-甲基哌啶-1-羧酸酯 顺式-6-甲基-哌啶-1,3-二甲酸1-叔丁酯 顺式-5-(三氟甲基)哌啶-3-羧酸甲酯盐酸盐 顺式-4-叔丁基-2-甲基哌啶 顺式-4-Boc-氨基哌啶-3-甲酸甲酯 顺式-4-(氮杂环丁烷-1-基)-3-氟哌 顺式-3-顺式-4-氨基哌啶 顺式-3-甲氧基-4-氨基哌啶 顺式-3-BOC-3,7-二氮杂双环[4.2.0]辛烷 顺式-3-(1-吡咯烷基)环丁腈 顺式-3,5-哌啶二羧酸 顺式-3,4-二溴-3-甲基吡咯烷盐酸盐 顺式-2,6-二甲基-4-氧代哌啶-1-羧酸叔丁基酯 顺式-1-叔丁氧羰基-4-甲基氨基-3-羟基哌啶 顺式-1-boc-3,4-二氨基哌啶 顺式-1-(4-叔丁基环己基)-4-苯基-4-哌啶腈 顺式-1,3-二甲基-4-乙炔基-6-苯基-3,4-哌啶二醇 顺-4-(4-氟苯基)-1-(4-异丙基环己基)-4-哌啶羧酸 顺-4-(2-氟苯基)-1-(4-异丙基环己基)-4-哌啶羧酸 顺-3-氨基-4-氟哌啶-1-羧酸叔丁酯 顺-1-苄基-4-甲基哌啶-3-氨基酸甲酯盐酸盐 非莫西汀 雷芬那辛 雷拉地尔 阿维巴坦中间体4 阿格列汀杂质 阿尼利定盐酸盐 CII 阿尼利定 阿塔匹酮 阿哌沙班杂质BMS-591455 阿哌沙班杂质87 阿哌沙班杂质52 阿哌沙班杂质51 阿哌沙班杂质5 阿哌沙班杂质 阿哌沙班杂质 阿哌沙班-d3 阿哌沙班 阻聚剂701 间氨基谷氨酰胺